Fasting serum fructose is associated with metabolic dysfunction-associated fatty liver disease: A prospective study.

Yujuan FanYuecheng ZhangCongling ChenZhen YingQing SuXiaoying LiYing Chen

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)

Fasting serum fructose concentration, which mostly reflects endogenous fructose, was associated with a higher risk of MAFLD. The FFI derived from fasting serum fructose could be used to predict MAFLD. This article is protected by copyright. All rights reserved.

Keyphrases

blood glucose
insulin resistance
type diabetes
metabolic syndrome
adipose tissue